3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
1
Meningioma
1
Interventions
Hydroxyurea
4
aldesleukin
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
Everolimus
3
Temozolomide
2
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Psychiatric Rehabilitation
2
Proton Therapy
2
Paclitaxel
2
Laser Speckle Contrast Imaging
2
Filgrastim
2
Donepezil
2
Cyclophosphamide
2
Carmustine
2
Bortezomib
2
Bevacizumab
2
Aminolevulinic Acid
2
90Y-octreotide, DOTA-Tyr(3)-
2
vistusertib
1
vatalanib
1
trametinib
1
tozuleristide
1
temsirolimus
1
sonidegib
1
sargramostim
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Meningioma
×
HES 130-0.4
×
Clear all
NCT07476404
2026-03-17
GM-HES
Chiang Mai University
Completed
300 enrolled